Cardiac Implant Devices Market By Devices & By Condition 2020 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Cardiac implant devices market
Cardiac Implant Devices Market Analysis: By Devices (Pacemakers, ICDs, CRTs, Coronary Stents, Heart Valves, TAVI Valves); By Condition (Myocardial Ischemia, Arrhythmias, Acute Myocardial Infarction) - With Forecast (2015-2020)
Report Code : HCR 0032
Published: 30 July, 2015   No. of pages: 180

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
Cardiac Implantable devices aim to treat long term heart conditions such as heart failure. These devices are intended to detect any fluctuations in the cardiac system and rectify it automatically or provide support to organs and tissues. Advancement in technology, growing incidences of cardiovascular diseases such as coronary artery diseases (CAD), arrhythmia and launch of new and innovative cardiac products such as leadless pacemakers, subcutaneous defibrillators (S-ICDs) are some of the key drivers for the growth of this market.

The market will show a significant growth in the next few years and is expected to reach $43.4 billion by 2020 at a CAGR of 12.5%. Advancement in technology, growing incidences of cardiovascular diseases such as coronary artery diseases (CAD), atrial fibrillation and aortic aneurysms and launch of new and innovative cardiac products such as leadless pacemakers, subcutaneous defibrillators (S-ICDs) are some of the key drivers for the growth of this market.

In this report different market aspects are explored with particular focus on key market drivers, challenges, constraints and market landscape. The Global market has been thoroughly analyzed and carefully segmented by geographic locations based on major economic and topographical regions.



The market for Cardiac implantable devices is classified into several categories based on types of implantable devices, disease conditions and cardiac procedures. They can be utilized in the diagnosis and treatment of various disease conditions such as Myocardial Ischemia, Cardiac Arrest, Arrhythmia, Acute Myocardial Infarction and many others.

Among cardiac implantable devices, coronary stents devices are generating the largest revenue whereas in future TAVR (Transcatheter Aortic Valve Replacement) valves will capture major market segment.

Major market players are profiled along with company overview, financial status, business strategies, product portfolio, recent trends and developments.

The prominent players profiled in this report are:
  • Medtronic Inc.,
  • Boston Scientific Corporation
  • St. Jude Medical Inc.,
  • Abbott Vascular Inc.
  • Edwards Lifesciences Corporation.
The report details current market potential and future market growth in this industry. Overall the report contains the most detailed and in depth segmentation and analysis of the Global Cardiac Implantable Devices Market during the forecast period 2015-2020.
1. Cardiac Implant Devices Market Overview
2. Executive Summary
3. Cardiac Implant Devices - Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
       3.2.1. Product Benchmarking
       3.2.2. Patent Analysis
       3.2.3. End user profiling
       3.2.4. Top 5 Financials Analysis
4. Cardiac Implant Devices - Market Forces
   4.1. Market Drivers
   4.2. Market Constraints
   4.3. Market Challenges
   4.4. Attractiveness of the Industry
       4.4.1. Power of Suppliers
       4.4.2. Power of Customers
       4.4.3. Threat of New entrants
       4.4.4. Threat of Substitution
       4.4.5. Degree of Competition
5. Cardiac Implant Devices Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Opportunities Analysis
   5.3. Product lifecycle
   5.4. Pricing Analysis
6. Cardiac Implant Devices Market– By Devices 
   6.1. Cardiac Resynchronization Therapy Devices (CRT’S)
   6.2. Implantable Cardioverter Defibrillators (ICD’S)
   6.3. Implantable Cardiac Pacemakers (ICPs)
   6.4. Coronary Stents
   6.5. Heart Valve Replacement/Repair Devices
   6.6. TAVR (Transcatheter Aortic Valve Replacement) Valves
7. Cardiac Implant Devices Market- By Disease Conditions
   7.1. Myocardial Ischemia
   7.2. Acute Myocardial Infarction
   7.3. Arrhythmias
   7.4. Others
8. Cardiac Implant Devices Market Classification- By Procedure
   8.1. Cardiac Resynchronization Therapy (CRT)
   8.2. Minimally Invasive Heart Surgery
   8.3. Open heart surgery
   8.4. Angioplasty
   8.5. Heart Valve Repair or Replacement
   8.6. Others
9. Cardiac Implant Devices Market -Geographic Analysis
   9.1. North America
       9.1.1. USA
       9.1.2. Canada
       9.1.3. Mexico
       9.1.4. Others
   9.2. Europe
       9.2.1. France
       9.2.2. Germany
       9.2.3. Italy
       9.2.4. Spain
       9.2.5. U.K
       9.2.6. Others
   9.3. APAC
       9.3.1. China
       9.3.2. India
       9.3.3. Japan
       9.3.4. Australia
       9.3.5. Others
   9.4. ROW
       9.4.1. South Africa
       9.4.2. Russia
       9.4.3. Middle East
       9.4.4. Others
10. Market Entropy
   10.1. New Product Launches
   10.2. M&As, Collaborations, JVs and Partnerships
11. Company profiles
   11.1. Abbott Vascular Inc.
   11.2. Medtronic, Inc.
   11.3. Biotronik, Inc.
   11.4. Bentley InnoMed GmbH
   11.5. Elestim-Cardio
   11.6. Cardioelectronica GmbH
   11.7. Qualimed Innovative Medizinprodukte Gmbh
   11.8. Medico S.p.A
   11.9. Lepu Medical Technology
   11.10. Boston Scientific Corporation
   11.11. St. Jude Medical, Inc.
   11.12. Edwards Lifesciences Corporation
   11.13. Biosensors International Group, Ltd.
   11.14. Japan Lifeline Co., Ltd.
   11.15. Sorin S.p.A.
   11.16. JenaValve Technology Inc. 
   11.17. Opto Circuits Limited
   11.18. Hexacath
   11.19. MicroPort Scientific Corporation.
   11.20. Cardionovum GmbH
   11.21. Alvimedica
   11.22. Amaranth Medical
   11.23. Stentys SA
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
12. Appendix
   12.1. Abbreviations
   12.2. Sources
   12.3. Research Methodology
   12.4. Bibliography
   12.5. Compilation of Expert Insights
   12.6. Disclaimer
List of Tables

Table 1. Product Benchmarking, Coronary Stents. 
Table 2. Product Benchmarking, Implantable Cardiac Pacemakers. 
Table 3. Product Benchmarking, Implantable Cardioverter Defibrillators (ICD). 
Table 4. Product Benchmarking, Cardiac Resynchronization Therapy (CRT). 
Table 5. Product Benchmarking, Heart Valves
Table 6. Product Benchmarking, Transcatheter Aortic Valves Replacement Valves
Table 7. Cardiac Implant Devices Market, Top Five Financial Analysis. 
Table 8. Cost Comparison of Cardiac Surgical Treatment. 
Table 9. Cardiac Implants Devices Market, by Devices, by Value, 2014 – 2020 ($Million)
Table 10. Cardiac Implants Devices Market, by Devices, by Volume, 2014 – 2020 (Million Units)
Table 11. Cardiac Implants Devices Market, CRT, by Region, by Value, 2014 – 2020 ($Million).
Table 12. Cardiac Implants Devices Market Value, ICD, by Region, by Value, 2014 – 2020 ($Million)
Table 13. Cardiac Implant Devices Market, Pacemakers, by Region, by Value, 2014 – 2020 ($Million)
Table 14. Cardiac Implants Devices Market, Coronary Stents, by Region, by Value, 2014 – 2020 ($Million). 
Table 15. Cardiac Implant Devices Market, Heart Valves, by Region, by Value, 2014 – 2020 ($Million)
Table 16. Cardiac Implant Devices Market, TAVI Valves, by Region, by Value, 2014 – 2020 ($Million)
Table 17. Cardiac Implants Devices Market, By Regions, by Value, 2014-2020 ($Million).
Table 18. Cardiac Implants Devices Market, By Regions, by Volume, 2014-2020 (Million Units)
Table 19. Cardiac Implants Devices Market, Americas, by Value, 2014-2020 ($Million)
Table 20. Cardiac Implants Devices Market, Americas, by Volume, 2014-2020 (Million Units).
Table 21. Cardiac Implants Devices Market, Americas, by Devices, by Value, 2014-2020 ($Million)
Table 22. Cardiac Implant Devices Market, by Value, Europe, 2014-2020 ($Million). 
Table 23. Cardiac Implant Devices Industry, by Volume, Europe, 2014-2020 (Million Units).
Table 24. Cardiac Implant Devices Industry, by Devices, Europe, 2014-2020 ($Million).
Table 25. Cardiac Implant Devices Industry, by Value, Asia-Pacific, 2014-2020 ($Million).
Table 26. Cardiac Implant Devices Industry, by Volume, Asia-Pacific, 2014-2020 (Million Units)
Table 27. Cardiac Implant Devices Industry, by Device, Asia-Pacific, 2014-2020 ($Million).
Table 28. Cardiac Implant Devices Industry, by Value, Row, 2014-2020 ($Million).
Table 29. Cardiac Implant Devices Industry, Row, by Volume, 2014-2020 (Million Units).
Table 30. Cardiac Implant Devices Industry, by Device, Row, 2014-2020 ($Million).
Table 31. Cardiac Implant Devices Industry: Key Product Launches.
Table 32. Cardiac Implant Devices Industry: Key Partnerships.
Table 33. Cardiac Implant Devices Market: Key Acquisitions. 
Table 34. Abbott Vascular Inc., Products. 
Table 35. Abbott Vascular Inc., Developments
Table 36. Medtronic PLC, Products. 
Table 37. Medtronic PLC, Developments. 
Table 38. BIOTRONIK Inc., Products. 
Table 39. BIOTRONIK Inc., Developments. 
Table 40. COOK Medical INC, Products. 
Table 41. COOK Medical INC, Developments. 
Table 42. CARDIONOVUM GMBH, Products. 
Table 43. CARDIONOVUM GMBH, Developments. 
Table 44. ALVIMEDICA Health Investments INC, Products. 
Table 45. ALVIMEDICA Health Investments INC, Developments. 
Table 46. AMARANTH Medical, Products. 
Table 47. AMARANTH Medical, Developments. 
Table 48. STENSYS SA, Products. 
Table 49. STENSYS SA, Developments
Table 50. HEXACATH, Products. 
Table 51. OPTO Circuits (India) Ltd., Products. 
Table 52. OPTO Circuits (India) Ltd., Developments. 
Table 53. JENAVALVE Technology, Products. 
Table 54. MICROPORT Scientific Corporation, Products. 
Table 55. MICROPORT Scientific Corporation, Developments. 
Table 56. TRYTON Medical, Inc., Products. 
Table 57. TRYTON Medical, Inc., Developments. 
Table 58. BENTLEY INNOMED GMBH, Products. 
Table 59. BENTLEY INNOMED GMBH, Developments. 
Table 60. ELESTIM-Cardio, Products. 
Table 61. Cardio electronica, Products. 
Table 62. QUALIMED Innovative MEDIZINPRODUKTE GMBH, Products. 
Table 63. Medico S.P.A, Products. 
Table 64. LEPU Medical Technology Co., Ltd., Products. 
Table 65. LEPU Medical Technology Co., Ltd., Developments. 
Table 66. Boston Scientific Corporation, Products. 
Table 67. Boston Scientific Corporation, Developments. 
Table 68. St. Jude Medical, Inc., Products. 
Table 69. St. Jude Medical, Inc., Developments
Table 70. Edwards Life sciences Corporation, Products. 
Table 71. Edwards Life sciences Corporation, Developments. 
Table 72. MERIL Life sciences Pvt. Ltd., Products
Table 73. MERIL Life sciences Pvt. Ltd., Developments. 
Table 74. EUCATECH AG, Products. 
Table 75. Biosensors International Group, Ltd, Products. 
Table 76. Biosensors International Group, Ltd, Developments. 
Table 77. Japan Lifeline Co., Ltd., Products. 
Table 78. Japan Lifeline Co., Ltd., Developments. 
Table 79. SORIN S.P.A, Products. 
Table 80. SORIN S.P.A, Developments


List of Figures

Figure 1. Cardiac Implant Devices, Disease Conditions. 
Figure 2. Cardiac Implant Devices Market, by Devices
Figure 3. Cardiac Implant Devices Industry Revenue – by Geographic Region, 2014 (%).
Figure 4. Cardiac Implant Devices Industry, Market Share Analysis, 2014 (%)
Figure 5. Cardiac Implant Devices Industry, Patent Analysis.
Figure 6. Cardiac Implant Devices Industry - Value Chain Analysis.
Figure 7. Cardiac Implant Devices Industry, Product/Market Lifecycle Analysis - ICDS, CRTS, Heart Valve Prosthetics and TAVR Valves
Figure 8. Cardiac Implants Devices Market, Product/Market Lifecycle Analysis – Pacemakers, Coronary Stents.
Figure 9. Cardiac Implant Devices Industry Revenue – by Geographic Region, 2014 (%).
Figure 10. Cardiac Implant Devices Market Strategy, 2012-15 (%). 
Figure 11. Abbott Vascular Inc.: Financial Performance, Total Revenues 2012-2014, ($Billion)
Figure 12. Abbott Vascular Inc.: Total Revenue, by Region, 2014 (%). 
Figure 13. Abbott Vascular Inc.: Total Revenue, by Segments, 2014 (%). 
Figure 14. Financial Performance, Total Revenues, 2010-2014, ($Billion). 
Figure 15. Medtronic Plc. Total Revenue, by Region, 2014 (%). 
Figure 16. Medtronic Plc. Total Revenue, by Segments, 2014 (%). 
Figure 17. OPTO Circuits Limited: Financial Performance, 2012-2014, ($Billion). 
Figure 18. OPTO Circuits Limited: Total Revenue, by Region, 2013 (%). 
Figure 19. OPTO Circuits Limited: Total Revenue, by Segments, 2013 (%). 
Figure 20. MICROPORT Scientific Corporation: Financial Performance, 2010-2014, ($Billion). 
Figure 21. MICROPORT Scientific Corporation: Total Revenue, by Segment, 2014(%)
Figure 22. MICROPORT Scientific Corporation: Total Revenue, by Region, 2014(%). 
Figure 23. Boston Scientific Corporation: Financial Performance, 2010-2014, ($Billion)
Figure 24. Boston Scientific Corporation: Total Revenue, by Segments, 2014 (%). 
Figure 25. Boston Scientific Corporation: Total Revenue, by Region, 2014 (%). 
Figure 26. St. Jude Medical, Inc.: Financial Performance, 2011-2014, ($Billion). 
Figure 27. St. Jude Medical, Inc.: Total Revenue, by Region, 2014 (%). 
Figure 28. St. Jude Medical, Inc.: Total Revenue, by Segments, 2014 (%). 
Figure 29. Edwards Life sciences Corporation: Financial Performance, 2011-2014, ($Billion). 
Figure 30. Edwards Life sciences Corporation, Total Revenue, by Segments, 2014 (%). 
Figure 31. Edwards Life sciences Corporation, Total Revenue, by Region, 2014 (%)
Figure 32. Biosensors International Group, Ltd.: Financial Performance, 2011-2014, ($Million). 
Figure 33. Biosensors International Group, Ltd.: Total Revenue, by Segment, 2014 (%). 
Figure 34. Biosensors International Group, Ltd.: Total Revenue, by Region, 2014 (%). 
Figure 35. Japan Lifeline Co., Ltd.: Financial Performance, 2011-2014, ($Million). 
Figure 36. Japan Lifeline Co., Ltd.: Total Revenue, by Segments, 2014 (%). 
Figure 37. Financial Performance, 2011-2014, ($Billion). 
Figure 38. SORIN S.P.A. Total Revenue, by Region, 2014 (%). 
Figure 39. SORIN S.P.A. Total Revenue, by Segments, 2014 (%)


Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports